SEASONAL ALLERGIC RHINITIS
Clinical trials for SEASONAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new SEASONAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for SEASONAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug offers hope for severe cedar allergy sufferers
Symptom relief CompletedThis study tested whether adding omalizumab to standard allergy medications (antihistamines and nasal sprays) could better control symptoms in 337 adults and teens with severe Japanese cedar pollinosis. Participants had severe symptoms despite current treatments. The study compar…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 12:58 UTC
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested a single dose of a new drug called MT-2990 in 75 adults with seasonal allergies from Japanese cedar pollen. The main goals were to check safety and how the drug moves through the body. Participants also spent time in a special room with controlled po…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 17, 2026 12:54 UTC
-
Two-Day allergy pill Pre-Treatment shows promise in ragweed season
Symptom relief CompletedThis study tested whether taking the allergy medicine fexofenadine for two days before ragweed season starts can reduce symptoms like sneezing, runny nose, and itchy eyes. 95 adults with ragweed allergies were randomly given either fexofenadine or a placebo. The results suggest t…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New allergy shot shows promise in phase 2 trial
Symptom relief CompletedThis study tested an injection called TQC2938 in 136 adults with seasonal allergic rhinitis (hay fever). All participants also used a standard nasal spray. The goal was to see if the injection reduces nasal symptoms like sneezing and congestion better than a placebo. The trial is…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New allergy shot shows promise for those failed by standard meds
Symptom relief CompletedThis study tested a new drug called LP-003 in 180 adults with moderate to severe seasonal allergies that were not well controlled by standard treatments like antihistamines or nasal sprays. LP-003 is a lab-made antibody that blocks IgE, a key driver of allergic reactions, and is …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC